DNA Vaccines Against Dengue Virus Type 2
Author Information
Author(s): Azevedo Adriana S., Yamamura Anna M. Y., Freire Marcos S., Trindade Gisela F., Bonaldo Myrna, Galler Ricardo, Alves Ada M. B.
Primary Institution: Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil
Hypothesis
Can DNA vaccines encoding the dengue virus envelope protein induce protective immune responses in mice?
Conclusion
The DNA vaccine pE1D2 provided complete protection against dengue virus, while pE2D2 offered only partial protection.
Supporting Evidence
- All pE1D2-vaccinated mice survived challenge with dengue virus.
- Only 10% of pE1D2-immunized mice showed clinical signs of infection after challenge.
- Levels of neutralizing antibodies were significantly higher in pE1D2-vaccinated mice than in pE2D2-immunized animals.
Takeaway
Scientists created two types of DNA vaccines to protect mice from dengue virus. One vaccine worked really well, keeping all the mice safe, while the other one didn't work as well.
Methodology
Two DNA vaccines were constructed and tested in Balb/c mice, followed by a challenge with a lethal dose of dengue virus.
Limitations
The study used a mouse model, which may not fully replicate human responses to the vaccine.
Participant Demographics
Balb/c mice, 4 to 6 weeks old.
Statistical Information
P-Value
0.0027
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website